logo

Health Care News

Share

Nemaura Medical Q1 Loss Per Share $0.17 Vs Loss $0.14 Last Year

Viridian Announces Positive Initial Clinical Data From Phase 1/2 Trial Of VRDN-001 In Thyroid Eye Disease

AstraZeneca Reports Positive High-level Results From DESTINY-Breast02 Phase III Trial Of Enhertu

Roche Announces Launch Of Elecsys IGRA SARS-CoV-2 Test

Biofrontera Q2 Net Loss $0.9 Mln Or $0.05/Shr Vs Loss Of $3.7 Mln Or $0.46/Shr Last Year

Aptinyx Says Phase 2b Study Of NYX-2925 In Fibromyalgia Fails To Meet Primary Endpoint

PLx Pharma Q2 Total Revenues $0.5 Mln; Initiates Evaluation Of Strategic Alternatives

UNITY Biotechnology Announces Positive Data In Phase 2 BEHOLD Study Of UBX1325 In Diabetic Macular Edema

Cerevel Therapeutics Prices Public Offering Of 7.25 Mln Shares At $35/Shr

GSK Plc Issues Statement On Zantac Litigation

Roche Announces FDA Approval Of Xofluza To Treat Influenza In Children Aged Five Years And Older